Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PAIN CARE SPECIALISTS OF OREGON, LLC

NPI: 1942675467 · SALEM, OR 97301 · Pain Medicine (Anesthesiology) Physician · NPI assigned 12/09/2015

$792K
Total Medicaid Paid
44,032
Total Claims
33,358
Beneficiaries
10
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialOH, ANDREW (MEDICAL DIRECTOR)
NPI Enumeration Date12/09/2015

Related Entities

Other providers sharing the same authorized official: OH, ANDREW

ProviderCityStateTotal Paid
CAPITAL WOMEN'S CARE, L.L.C. FULTON MD $28.69M
APEX CARE CENTER LLC SANTA ANA CA $528.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,914 $115K
2019 5,971 $138K
2020 5,824 $116K
2021 9,681 $126K
2022 8,733 $128K
2023 6,424 $98K
2024 3,485 $71K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 24,593 18,634 $619K
99484 9,181 7,302 $75K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,866 3,544 $50K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 3,876 2,709 $34K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 941 727 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 53 51 $3K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 108 88 $2K
80306 298 239 $1K
76942 102 52 $534.87
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14 12 $199.13